New Scientist - 02.18.2020

(C. Jardin) #1
8 February 2020 | New Scientist | 5

FOR those of us who turn to science
for answers, the Wuhan coronavirus
outbreak is unsettling. We don’t know
what proportion of infected people are
likely to die (see page 9); our figures
for how many other people on average
each carrier infects are only estimates;
and the total number of cases is likely
to be far higher than those confirmed
so far. These three parameters are crucial
for epidemiologists who use models
to calculate how bad an outbreak will
get, but we don’t yet know what values
to punch into the models.
As cases in China soar, the list of
unknowns gets even longer. It remains
unclear whether the virus can spread
before symptoms show. We don’t yet
know how or when the virus is likely
to have crossed over from bats (see page
10), or why the first known human case

of the virus seems to have no connection
to the Wuhan food market where the
outbreak appears to have begun. Is every
case equally infectious, or are some
people unlikely to pass it on, while
others act as super-spreaders? And is the
virus only deadly for those who are older
or who already have chronic conditions?

What we do know is that the outbreak
is likely to go one of three ways (see
page 8). As this magazine went to press,
the outbreak seemed on the verge
of becoming a pandemic – in which
multiple epidemics of an infection take
place across the world. From here, the

virus may either peter out or go truly
global. We can’t know yet how many
lives this would claim.
If it goes global, it could one day
resemble flu, which every year causes an
estimated 3 to 5 million cases of severe
illness, and about 290,000 to 650,
deaths. Flu can cause mild symptoms
in some people and much worse ones in
others, and most deaths occur in people
over the age of 65 – all of which may be
true for the new coronavirus.
There is another option. The race is
now on to find drugs and vaccines that
could help bring the virus under control
and prevent global exposure. While drug
development will take time, trials of
existing drugs are already under way in
China (see page 11). If successful, we may
be able to save many lives – although we
can’t yet calculate the number. ❚

Deadly unknowns


We are still scrambling to understand how dangerous the Wuhan coronavirus is


The leader


“If the virus goes global, it could
one day resemble flu, which
every year causes hundreds
of thousands of deaths”

EDITORIAL
Chief executive Nina Wright
Finance director Amee Dixon
Chief technology officer Chris Corderoy
Marketing director Jo Adams
Human resources Shirley Spencer
HR coordinator Serena Robinson
Facilities manager Ricci Welch
Executive assistant Lorraine Lodge
Receptionist Alice Catling

Non-exec chair Bernard Gray
Senior non-exec director Louise Rogers

MANAGEMENT

CONTACT US
newscientist.com/contact
General & media enquiries
US Tel +1 617 283 3213
PO Box 80247, Portland, OR 97280
UK Tel +44 (0)20 7611 1200
25 Bedford Street, London WC2E 9ES
Australia 418A Elizabeth St, Surry Hills, NSW 2010
US Newsstand
Tel +1 973 909 5819
Distributed by Time Inc. Retail, a division of Meredith
Corporation, 6 Upper Pond Road, Parsippany, NJ 07054
Syndication
Tribune Content Agency
Tel 1-800-346-8798 Email [email protected]
Subscriptions
newscientist.com/subscribe
Tel 1 888 822 3242
Email [email protected]
Post New Scientist, PO Box 3806, Chesterfield MO 63006-

PUBLISHING & COMMERCIAL

© 2020 New Scientist Ltd, England. New Scientist ISSN 0262 4079 is
published weekly except for the last week in December by New Scientist Ltd,
England. New Scientist (Online) ISSN 2059 5387. New Scientist Limited,
387 Park Avenue South, New York, NY 10016
Periodicals postage paid at New York, NY and other mailing offices
Postmaster: Send address changes to New Scientist, PO Box 3806,
Chesterfield, MO 63006-9953, USA.
Registered at the Post Office as a newspaper and printed in USA by
Fry Communications Inc, Mechanicsburg, PA 17055

Editor Emily Wilson
Executive editor Richard Webb
Creative director Craig Mackie
News
News editor Penny Sarchet
Editors Lilian Anekwe, Jacob Aron, Chelsea Whyte
Reporters (UK) Jessica Hamzelou, Michael Le Page,
Donna Lu, Adam Vaughan, Clare Wilson
(US) Leah Crane
(Aus) Alice Klein
Interns Gege Li, Layal Liverpool, Jason Arunn Murugesu
Digital
Digital editor Conrad Quilty-Harper
Podcast editor Rowan Hooper
Web team Anne Marie Conlon,
David Stock, Sam Wong
Features
Head of features Catherine de Lange
and Tiffany O’Callaghan
Editors Gilead Amit, Julia Brown, Daniel Cossins,
Kate Douglas, Alison George
Feature writer Graham Lawton
Culture and Community
Comment and culture editor Timothy Revell
Editors Liz Else, Mike Holderness, Simon Ings
Education editor Joshua Howgego
Subeditors
Chief subeditor Eleanor Parsons
Bethan Ackerley, Tom Campbell, Chris Simms, Jon White
Design
Art editor Kathryn Brazier
Joe Hetzel, Dave Johnston, Ryan Wills
Picture desk
Tim Boddy
Production
Production manager Alan Blagrove
Robin Burton, Melanie Green

Display advertising
Tel +44 (0)20 7611 1291 Email [email protected]
Commercial director Chris Martin
Display sales manager Justin Viljoen
Lynne Garcia, Bethany Stuart, Henry Vowden,
(ANZ) Richard Holliman
Recruitment advertising
Tel +44 (0)20 7611 1204 Email [email protected]
Recruitment sales manager Viren Vadgama
Deepak Wagjiani, (US) Jeanne Shapiro
New Scientist Live
Tel +44 (0)20 7611 1245 Email [email protected]
Events director Adrian Newton
Creative director Valerie Jamieson
Event manager Henry Gomm
Sales director Jacqui McCarron
Exhibition sales manager Rosie Bolam
Marketing manager Katie Cappella
Events team support manager Rose Garton
Marketing executive Jessica Lazenby-Murphy
New Scientist Discovery Tours
Director Kevin Currie
Marketing
Head of campaign marketing James Nicholson
Digital marketing manager Poppy Lepora
Head of customer experience Emma Robinson
Email/CRM manager Rose Broomes
Head of data analytics Tom Tiner
Web development
Maria Moreno Garrido, Tom McQuillan, Amardeep Sian
Piotr Walkow
Free download pdf